12.3 Neonatal Hypoglycemia, Thermoregulation & the Infant of a Diabetic Mother

Neonatal Hypoglycemia: Pathophysiology, Screening & Treatment

During gestation, maternal glucose crosses the placenta via facilitated diffusion, maintaining fetal blood glucose at roughly 70% to 80% of maternal concentrations. The fetus produces its own insulin. At delivery, the umbilical cord is clamped, abruptly terminating the maternal glucose supply while high circulating fetal insulin levels persist. Normal term neonates compensate by mobilizing hepatic glycogen stores via glycogenolysis and inducing gluconeogenesis, experiencing a physiological nadir in blood glucose at 1 to 2 hours of life before stabilizing.

High-Risk Target Populations for Hypoglycemia Screening

Routine blood glucose screening is NOT recommended for healthy, asymptomatic term infants. Screening is indicated exclusively for neonates with specific clinical risk factors:

1. Infants of Diabetic Mothers (IDM): Maternal hyperglycemia causes fetal hyperglycemia, inducing hypertrophy and hyperplasia of fetal pancreatic beta-cells. After delivery, excessive endogenous insulin secretion causes profound hyperinsulinemic hypoglycemia.
2. Large for Gestational Age (LGA): Birth weight >90th percentile (hyperinsulinism).
3. Small for Gestational Age (SGA) & Intrauterine Growth Restriction (IUGR): Birth weight <10th percentile. Compromised placental nutrient transport results in severely depleted hepatic glycogen stores, minimal adipose tissue, and impaired gluconeogenesis.
4. Late Preterm Infants (34 0/7 to 36 6/7 weeks): Immature hepatic enzyme systems, reduced glycogen reserves, and poor suck-swallow-breathe coordination.
5. Perinatal Stress & Sepsis: Perinatal asphyxia, hypothermia, meconium aspiration, maternal chorioamnionitis, or polycythemia (elevated metabolic consumption).

Clinical Thresholds & Screening Protocols (AAP Guidelines)

• Timing: In at-risk infants, initiate feeding within 30 to 60 minutes of birth. Measure blood glucose 30 minutes after the first feeding, and before subsequent feedings every 2 to 3 hours for the first 12 to 24 hours.
• Diagnostic Action Thresholds:
  • Birth to 4 hours of life: Target blood glucose is ≥40 mg/dL. Clinical action threshold: <40 mg/dL.
  • 4 to 24 hours of life: Target blood glucose is ≥45 mg/dL. Clinical action threshold: <45 mg/dL.
• Signs of Neonatal Hypoglycemia: Jitteriness, tremors, hypotonia (floppiness), lethargy, poor feeding, hypothermia, tachypnea, weak or high-pitched cry, cyanosis, apnea, and seizures.

Stepwise Neonatal Hypoglycemia Management Cascade
├── Asymptomatic & Glucose <40 mg/dL (0-4h) or <45 mg/dL (4-24h)
│   ├── Step 1: Administer Oral 40% Dextrose Gel 0.5 mL/kg into buccal mucosa + Feed immediately
│   ├── Step 2: Recheck blood glucose in 30 to 60 minutes
│   └── Step 3: If glucose remains below threshold after 2 doses of gel ──> Transfer for IV D10W
└── Symptomatic Hypoglycemia (Any glucose <40 mg/dL with symptoms) OR Refractory Hypoglycemia
    ├── Step 1: Administer D10W (10% Dextrose) IV Bolus: 2 mL/kg (200 mg/kg) over 5-10 minutes
    └── Step 2: Initiate Continuous IV Dextrose Infusion: Glucose Infusion Rate (GIR) 6-8 mg/kg/min

• First-Line Intervention — Oral 40% Dextrose Gel: For asymptomatic hypoglycemia, oral 40% dextrose gel (0.5 mL/kg) massaged into the infant's buccal mucosa, combined with breast milk or formula feeding, is the evidence-based standard of care. Dextrose gel provides rapid transmucosal absorption, avoids separation of the maternal-infant dyad, and significantly reduces NICU admissions for IV therapy.
• Intravenous Dextrose Resuscitation: Indicated for any infant with symptomatic hypoglycemia, or asymptomatic infants whose blood glucose remains persistently below threshold despite feeding and two doses of dextrose gel:
  • Administer an IV bolus of 10% Dextrose in Water (D10W) at 2 mL/kg (200 mg/kg) over 5 to 10 minutes.
  • Immediately initiate a continuous maintenance IV dextrose infusion at a Glucose Infusion Rate (GIR) of 6 to 8 mg/kg/min, calculated as: $\text{GIR (mg/kg/min)} = \frac{\text{Fluid Rate (mL/hr)} \times \text{Dextrose Concentration (\%)} \times 0.167}{\text{Weight (kg)}}$
  • Precaution: Never administer concentrated dextrose (e.g., D25W or D50W) as an IV push; hypertonic solutions cause osmotic endothelial damage, intracranial hemorrhage, and trigger severe reactive rebound hyperinsulinemic hypoglycemia.

---

Neonatal Thermoregulation and Cold Stress

Supporting thermoregulation is a distinct blueprint task and the single intervention most often responsible for preventing the hypoglycemia just described.

Why Newborns Lose Heat So Fast

• A large surface-area-to-mass ratio, thin skin, minimal subcutaneous fat, and a wet body surface at birth.
• Newborns cannot shiver. They generate heat by non-shivering thermogenesis: norepinephrine triggers lipolysis in brown adipose tissue (interscapular region, nape of the neck, axillae, and around the kidneys and adrenals), where uncoupling protein-1 dissipates the proton gradient as heat instead of ATP.

The Four Routes of Heat Loss

The Cold-Stress Cascade

Hypothermia is not merely uncomfortable — it sets off a self-reinforcing spiral:

Cold stress → increased oxygen and glucose consumption → hypoglycemia → anaerobic metabolism → metabolic acidosis → pulmonary vasoconstriction with worsening hypoxemia → reduced surfactant production → further cold stress.

Thresholds (axillary): normal 36.5–37.5 °C; cold stress below 36.5 °C; moderate hypothermia below 36.0 °C.

Practical Prevention

Skin-to-skin contact with the mother is the most effective warming intervention for a stable newborn and outperforms a radiant warmer for thermal stability, glycemic stability, and breastfeeding success. Add a dry hat, cover both with a warmed blanket, and delay the first bath for at least 24 hours or until the temperature has been stable for several hours. For preterm infants below about 32 weeks, place the infant in a polyethylene wrap or bag without drying and use a warmed mattress.

The Infant of a Diabetic Mother

Infants of diabetic mothers concentrate several of these problems at once and should be assessed as a cluster: macrosomia with birth trauma risk, hyperinsulinemic hypoglycemia, hypocalcemia and hypomagnesemia, polycythemia (hematocrit above 65%) with subsequent hyperbilirubinemia, respiratory distress from insulin-impaired surfactant synthesis, and asymmetric septal hypertrophy. Infants of mothers with pregestational diabetes also carry an increased risk of structural anomalies — cardiac defects, neural tube defects, and caudal regression sequence — reflecting first-trimester hyperglycemia.